Skip to content

Endoscopic subserosal dissection for gastric tumors : A retrospective singlecenter study

Endoscopic subserosal dissection for gastric tumors : A retrospective singlecenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005678
Enrollment
18
Registered
2020-12-15
Start date
2019-12-24
Completion date
Unknown
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Presbyterian Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patients who have subepithelial tumor indicated to be treated with ESSD 2. ECOG performance status 0-2 3. ANC > 1500/mm3, Platelet > 100,000/mm3 4. Creatinine < 1.5 x normal upper level 5. AST, ALT < 2.5 x normal upper level, total bilirubin < 1.5 x normal upper level 6. the patients who agree with informed consent

Exclusion criteria

Exclusion criteria: 1. The patients who are not indicated to ESSD 2. The patients who have allergic history to drug related with treatment 3. The patients who have angina pectoris, acute myocardial infarction, or liver cirrhosis history within 6 months 4. The patients who have severe acute infection 5. The patients who loose medical record

Design outcomes

Primary

MeasureTime frame
the mean age, sex, mean operation duration, the mean length of the long axis of the specimen

Secondary

MeasureTime frame
complication

Countries

Korea, Republic of

Contacts

Public ContactJihyun Han

Presbyterian Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026